Clinical Trials and Similar Human Studies
Last updated: 2021 Sep 7
Total hit(s): 249
S.No.
1
34346827
Safety, tolerability, pharmacokinetic characteristics, and immunogenicity of MW33: a Phase 1 clinical study of the SARS-CoV-2 RBD-targeting monoclonal antibody
Emerg Microbes Infect
2021 Dec
5.84
1
2
34473254
Adalimumab and infliximab impair SARS-CoV-2 antibody responses: results from a therapeutic drug monitoring study in 11422 biologic-treated patients
J Crohns Colitis
2021 Sep 2
6.97
1
3
34473343
SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19
Cochrane Database Syst Rev
2021 Sep 2
3.22
1
4
34473652
A multicenter randomized open-label clinical trial for convalescent plasma in patients hospitalized with COVID-19 pneumonia
J Clin Invest
2021 Sep 2
10.51
1
5
34472583
Similar antibody responses against SARS-CoV-2 in HIV uninfected and infected individuals on antiretroviral therapy during the first South African infection wave
Clin Infect Dis
2021 Sep 2
7.71
1
6
34244956
Efficacy and Safety of Tocilizumab Treatment COVID-19 Patients: A Case-Control Study and Meta-Analysis
Infect Dis Ther
2021 Sep
3.95
1
7
34373633
Multiple sclerosis treatment blunts SARS-CoV-2 antibody response
Nat Rev Neurol
2021 Sep
1
8
34321333
Impact of Disease-Modifying Treatments of Multiple Sclerosis on Anti-SARS-CoV-2 Antibodies: An Observational Study
Neurol Neuroimmunol Neuroinflamm
2021 Sep
7.6
1
9
34427065
Effectiveness of Convalescent Plasma Therapy in Severe or Critically Ill COVID-19 Patients: A Retrospective Cohort Study
Yonsei Med J
2021 Sep
1
10
34323287
Development of antibody response to SARS-CoV-2 following asymptomatic infection in patients with plasma cell disorders on immunomodulatory therapy
Br J Haematol
2021 Sep
5.02
1
11
34452007
Impact of Low-Dose Methotrexate-Adalimumab Combination Therapy on the Antibody Response Induced by the mRNA-1273 SARS-CoV-2 Vaccine: Case of an Elderly Patient with Rheumatoid Arthritis
Vaccines (Basel)
2021 Aug 9
2.7
1
12
34373446
Identification of potent human neutralizing antibodies against SARS-CoV-2 implications for development of therapeutics and prophylactics
Nat Commun
2021 Aug 9
11.8
1
13
34370690
Laboratory parameters predicting mortality of adult in-patients with COVID-19 associated cytokine release syndrome treated with high-dose tocilizumab
Acta Microbiol Immunol Hung
2021 Aug 6
1.12
1
14
34371010
A Novel Approach to Equitable Distribution of Scarce Therapeutics: Institutional Experience Implementing a Reserve System for Allocation of COVID-19 Monoclonal Antibodies
Chest
2021 Aug 6
7.22
1
15
34353339
Dexamethasone and tocilizumab treatment considerably reduces the value of C-reactive protein and procalcitonin to detect secondary bacterial infections in COVID-19 patients
Crit Care
2021 Aug 5
6.7
1
16
34350584
Successful treatment of COVID-19 infection with convalescent plasma in B-cell-depleted patients may promote cellular immunity
Eur J Immunol
2021 Aug 4
4.18
1
17
34463470
Liquid Chromatography-Multiple Reaction Monitoring-Mass Spectrometry Assay for Quantitative Measurement of Therapeutic Antibody Cocktail REGEN-COV Concentrations in COVID-19 Patient Serum
Anal Chem
2021 Aug 31
6.37
1
18
34311587
B.1.526 SARS-CoV-2 Variants Identified in New York City are Neutralized by Vaccine-Elicited and Therapeutic Monoclonal Antibodies
mBio
2021 Aug 31
6.5
4
19
34344651
Effective use of monoclonal antibodies for treatment of persistent COVID-19 infection in a patient on rituximab
BMJ Case Rep
2021 Aug 3
0.44
1
20
34344023
Dancing during labor in the midst of COVID-19 outbreak: as an alternative non-pharmacological treatment after digital interventions
J Public Health (Oxf)
2021 Aug 3
1.55
1
21
34456266
Preemptive Antibody Therapy for Vaccine Breakthrough SARS-CoV-2 Infection in Immunocompromised Patients
Transplantation
2021 Aug 27
8.2
1
22
34436742
Clinical efficacy and safety of combination therapy of tocilizumab and steroid pulse therapy for critical COVID-19 in HD patients
Clin Exp Nephrol
2021 Aug 26
1.68
1
23
34436756
Correction to: A cross‑section observational study on the seroprevalence of antibodies to COVID‑19 in patients receiving opiate agonist treatment
Ir J Med Sci
2021 Aug 26
0.99
1
24
34453934
Monoclonal antibody treatment of symptomatic COVID-19 in pregnancy: Initial report
Am J Obstet Gynecol
2021 Aug 25
5.73
1
25
34431691
Emergence of Multiple SARS-CoV-2 Antibody Escape Variants in an Immunocompromised Host Undergoing Convalescent Plasma Treatment
mSphere
2021 Aug 25
4.28
1